Profile
Jannik N.
Andersen is currently Chief Scientific Officer at Tango Therapeutics, Inc. since 2023, with employment at the company starting in 2019.
The education history includes undergraduate studies at Institut Polytechnique de Grenoble, graduate studies at the Technical University of Denmark, and a doctorate from the University of Copenhagen.
Jannik Andersen active positions
| Companies | Position | Start |
|---|---|---|
| TANGO THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 09/10/2023 |
Training of Jannik Andersen
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
Technical University of Denmark
Technical University of Denmark Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Copenhagen
University of Copenhagen Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Institut Polytechnique de Grenoble
Institut Polytechnique de Grenoble Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Tango Therapeutics, Inc.
Tango Therapeutics, Inc. BiotechnologyHealth Technology Operates as biotechnology company that engages in discovering and delivering precision cancer medicines | Health Technology |
- Stock Market
- Insiders
- Jannik Andersen
















